Skip to main content
DTIL
NASDAQ Life Sciences

DSMB Clears PBGENE-DMD Safety Review, Allowing Expanded Dosing in Duchenne Trial

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$8.57
Mkt Cap
$226.838M
52W Low
$3.53
52W High
$9.62
52W Position info
143% above low
Off High info
11% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

DTIL has more than doubled off its 52-week low of $3.53.

Summary

The independent Data Safety Monitoring Board reviewed the first FUNCTION-DMD patient's eight-week safety data and found no serious adverse events or adverse events of special interest, clearing Precision to dose additional patients in Part 1. That is the key gating step for an AAV-delivered in vivo gene editing program, where early immune and safety signals are the main reason trials stall. The readout is for PBGENE-DMD in Duchenne muscular dystrophy, a separate program from the PBGENE-HBV hepatitis B data released earlier today, so it broadens the clinical story rather than repeating it. The company said it looks forward to safety and efficacy updates from FUNCTION-DMD throughout 2027. Cash of $108.0M with runway guided through 2028, per the Q3 filing, means this program is funded without an immediate raise, though a shelf offering was also filed today.

At the time of this announcement, DTIL was trading at $8.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $226.8M. The 52-week trading range was $3.53 to $9.62. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

DTIL - Latest Insights

DTIL
Nov 05, 2026, 7:10 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $7.73
Real-time Price: $7.40 info
Change: -$0.330 (-4%) info
Market Cap: $206.724M info
DTIL
Nov 05, 2026, 7:07 AM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $7.40 info
Change: -$1.10 (-13%) info
Market Cap: $206.724M info
DTIL
Nov 05, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.39
Real-time Price: $7.40 info
Change: -$0.990 (-12%) info
Market Cap: $206.724M info
DTIL
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $8.39
Real-time Price: $7.40 info
Change: -$0.990 (-12%) info
Market Cap: $206.724M info
DTIL
Nov 03, 2026, 8:58 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.33
Real-time Price: $7.40 info
Change: +$0.070 (+0.95%) info
Market Cap: $206.724M info